PEPTIDES THAT TARGET DORSAL ROOT GANGLION NEURONS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150098990A1
SERIAL NO

14509989

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns methods and compositions that employ peptides that target dorsal root ganglion (DRG) neurons. In particular, the peptides are used to target therapeutic agents, such as proteins, liposomes, or viral particles comprising therapeutic polynucleotides, to one or more peripheral neuropathies or neuropathic pain, for example. In particular cases, the peripheral neuropathies or neuropathic pain is caused directly or indirectly by DRG neuronopathy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYLOR COLLEGE OF MEDICINEONE BAYLOR PLAZA HOUSTON TX 77030

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chan, Lawrence Houston, US 13 93
Kojima, Hideto Otsu Shiga, JP 11 42
Terashima, Tomoya Otsu, JP 8 109

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation